Viimane versioon :
28/04/2024
Uurimisrühmad - Upjohn Company, Clinical Biopharmaceutics Research   Pdf  
Ameerika ühendriigid
Farmaatsialaboratoorium
Upjohn Company, Clinical Biopharmaceutics Research
Kalamazoo
Email
Viited   Viited   (3)  
1
Compatibility and stability of clindamycin phosphate with intravenous fluids.
Porter WR, Johnson CA, Cohon MS, Gillespie W. ()
Am J Hosp Pharm - 1983 - ; 40: 91-94.
2
Cytosine arabinose stability in intravenous admixtures with sodium bicarbonate and in plastic syringes.
Munson J, Kubiak EJ, Cohon MS. ()
Drug Intell Clin Pharm - 1982 - ; 16: 765-767.
3
Stability of prostaglandins.
Roseman TJ, Sims B, Stehle RG. ()
Am J Hosp Pharm - 1973 - ; 30: 236-239.

Ingredientide nimekiri   Molekulid uuritud   (4)  
Antibiootikum Süsteravim Clindamycin phosphate
Vähiravimite Süsteravim Cytarabine
Mitmesugune Süsteravim Dinoprostone
Elektrolüüt Süsteravim Sodium bicarbonate

  Mentions Légales